(Q45936271)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584827%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

title

Brazilian experience with two conditioning regimens in patients with multiple sclerosis: BEAM/horse ATG and CY/rabbit ATG (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584827%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584827%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Angela Tavares Paes

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584827%20AND%20SRC:MED&resulttype=core&format=json

Maria Carolina O Rodrigues

2 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584827%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Belinda Pinto Simoes

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584827%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Amilton Antunes Barreira

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584827%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

José Mauro Kutner

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584827%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

author name string

D A Moraes

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584827%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

M C Oliveira

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584827%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

A B P L Stracieri

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584827%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

F Pieroni

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584827%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

G M N Barros

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584827%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

M I A Madeira

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584827%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

D G Brum

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584827%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

A A F Ribeiro

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584827%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

C P Tylberi

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584827%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

P P Porto

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584827%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

C L Santana

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584827%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

J Z Neto

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584827%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

J C Barros

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584827%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

R K Burt

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584827%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

E A Oliveira

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584827%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

A P Mastropietro

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584827%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

A C Santos

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584827%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

J C Voltarelli

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584827%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

language of work or name

English

0 references

publication date

6 July 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584827%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

2 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584827%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584827%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584827%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

page(s)

239-248

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584827%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/bmt.2009.127

2 February 2020

exact match

0 references

cites work

New concepts in the immunopathogenesis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.127

Genetics of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.127

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.127

Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.127

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.127

Natalizumab is effective as second line therapy in the treatment of relapsing remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.127

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.127

Long-term observations of autoimmune-prone mice treated for autoimmune disease by allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.127

Autologous stem cell transplantation for treatment of autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.127

Immune ablation and stem-cell therapy in autoimmune disease. Experimental basis for autologous stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.127

Stem cell transplantation in experimental models of autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.127

Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.127

Autologous haematopoietic-stem-cell transplantation for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.127

Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.127

Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: report of toxicity and immunological monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.127

High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.127

Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.127

Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.127

Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.127

Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.127

Autologous non-myeloablative hematopoietic stem cell transplantation in patients with systemic sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.127

Immunoablative therapy with autologous stem cell transplantation in the treatment of poor risk multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.127

Intense T cell depletion followed by autologous bone marrow transplantation for severe multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.127

High-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation as a treatment option in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.127

Reduced-intensity conditioning in children: a reappraisal in 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.127

Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.127

Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.127

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.127

Guidelines for autologous blood and marrow stem cell transplantation in multiple sclerosis: a consensus report written on behalf of the European Group for Blood and Marrow Transplantation and the European Charcot Foundation. BMT-MS Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.127

Improving interobserver variation in reporting gadolinium-enhanced MRI lesions in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.127

Hematopoietic stem cell transplantation for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.127

Autologous haematopoietic stem-cell transplantation in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.127

Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.127

Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.127

Immunology of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.127

7 January 2021

Tolerance induction by bone marrow transplantation in a multiple sclerosis model

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.127

7 January 2021

T cell-depleted autologous hematopoietic stem cell transplantation for multiple sclerosis: report on the first three patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.127

7 January 2021

Autologous stem cell transplantation for progressive multiple sclerosis: Update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.127

7 January 2021

Hematopoietic stem cell transplantation for progressive multiple sclerosis: failure of a total body irradiation-based conditioning regimen to prevent disease progression in patients with high disability scores

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.127

7 January 2021

Autologous hematopoietic stem cell transplantation for progressive multiple sclerosis: report of efficacy and safety at three yr of follow up in 21 patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.127

7 January 2021

Autologous peripheral blood stem cell transplantation for severe multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.127

7 January 2021

Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.127

7 January 2021

Analysis of immune reconstitution after autologous bone marrow transplantation in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.127

7 January 2021

Identifiers

DOI

10.1038/BMT.2009.127

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584827%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

2 February 2020

1006662570

0 references

1 reference